MHRA appoints DEKRA to certify medical devices
DEKRA has become the first organisation to complete the new designation process
Read More
Author: John Pinching
Shionogi reaches primary endpoint for ensitrelvir
Positive results in COVID-19 therapy phase 3 trials show effectiveness against five symptoms
Read More
Eisai’s Lecanemab phase 3 study meets primary endpoint
Results show reduction of clinical decline in global study of people with Alzheimer’s Disease
Read More
Research reveals chaotic schedule for myeloma patients
Myeloma diagnosis can take over five months, requiring several medical consultations
Read More
Modus completes recruitment for sevuparin study
Phase 1b study evaluates effects of sevuparin on the symptoms of volunteer participants
Read More- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
